176 related articles for article (PubMed ID: 10233465)
21. ["... The better to see you with"--phothodynamic diagnostic in superficial bladder cancer].
Forster TH; Wyler S; Ruszat R; Gasser TC; Bachmann A
Praxis (Bern 1994); 2007 Oct; 96(42):1631-7. PubMed ID: 17974123
[TBL] [Abstract][Full Text] [Related]
22. Hexyl aminolevulinate: in the detection of bladder cancer.
Frampton JE; Plosker GL
Drugs; 2006; 66(4):571-8; discussion 579-80. PubMed ID: 16597168
[TBL] [Abstract][Full Text] [Related]
23. Endoscopic fluorescence diagnosis and laser treatment of transitional cell carcinoma of the bladder.
Frimberger D; Zaak D; Hofstetter A
Semin Urol Oncol; 2000 Nov; 18(4):264-72. PubMed ID: 11101089
[TBL] [Abstract][Full Text] [Related]
24. Integral spectrophotometric analysis of 5-aminolaevulinic acid-induced fluorescence cytology of the urinary bladder.
Tauber S; Stepp H; Meier R; Bone A; Hofstetter A; Stief C
BJU Int; 2006 May; 97(5):992-6. PubMed ID: 16643481
[TBL] [Abstract][Full Text] [Related]
25. Fluorescence detection of bladder tumors with 5-amino-levulinic acid.
Riedl CR; Plas E; Pflüger H
J Endourol; 1999 Dec; 13(10):755-9. PubMed ID: 10646684
[TBL] [Abstract][Full Text] [Related]
26. Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection.
Zaak D; Frimberger D; Stepp H; Wagner S; Baumgartner R; Schneede P; Siebels M; Knüchel R; Kriegmair M; Hofstetter A
J Urol; 2001 Nov; 166(5):1665-8; discussion 1668-9. PubMed ID: 11586198
[TBL] [Abstract][Full Text] [Related]
27. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.
Grossman HB; Gomella L; Fradet Y; Morales A; Presti J; Ritenour C; Nseyo U; Droller MJ;
J Urol; 2007 Jul; 178(1):62-7. PubMed ID: 17499283
[TBL] [Abstract][Full Text] [Related]
28. Cystoscopic diagnosis of bladder cancer by intravesical instillation of 5-aminolevulinic acid induced porphyrin fluorescence--the Singapore experience.
Cheng CW; Lau WK; Tan PH; Olivo M
Ann Acad Med Singap; 2000 Mar; 29(2):153-8. PubMed ID: 10895330
[TBL] [Abstract][Full Text] [Related]
29. Photodynamic cystoscopy for detection of bladder tumors.
Kriegmair M; Zaak D; Knuechel R; Baumgartner R; Hofstetter A
Semin Laparosc Surg; 1999 Jun; 6(2):100-3. PubMed ID: 10459062
[TBL] [Abstract][Full Text] [Related]
30. Improved detection of nonmuscle invasive urothelial carcinoma of the bladder using pirarubicin endoscopy: a prospective, single-center preliminary study.
Han J; Lin T; Xu K; Jiang C; Huang H; Yin X; Xie W; Yao Y; Zhang C; Huang J
J Endourol; 2010 Nov; 24(11):1801-6. PubMed ID: 20932082
[TBL] [Abstract][Full Text] [Related]
31. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence.
Kriegmair M; Baumgartner R; Knüchel R; Stepp H; Hofstädter F; Hofstetter A
J Urol; 1996 Jan; 155(1):105-9; discussion 109-10. PubMed ID: 7490803
[TBL] [Abstract][Full Text] [Related]
32. Improving the management of bladder cancer with fluorescence cystoscopy.
Grossman HB
J Environ Pathol Toxicol Oncol; 2007; 26(2):143-7. PubMed ID: 17725540
[TBL] [Abstract][Full Text] [Related]
33. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
Marti A; Jichlinski P; Lange N; Ballini JP; Guillou L; Leisinger HJ; Kucera P
J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792
[TBL] [Abstract][Full Text] [Related]
34. Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?
Geavlete B; Multescu R; Georgescu D; Jecu M; Stanescu F; Geavlete P
BJU Int; 2012 Feb; 109(4):549-56. PubMed ID: 21711438
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of hexaminolevulinate fluorescence cystoscopy for the diagnosis of non-muscle-invasive bladder cancer in daily clinical practice: a Spanish multicentre observational study.
Palou J; Hernández C; Solsona E; Abascal R; Burgués JP; Rioja C; Cabrera JA; Gutiérrez C; Rodríguez O; Iborra I; Herranz F; Abascal JM; Conde G; Oliva J
BJU Int; 2015 Jul; 116(1):37-43. PubMed ID: 25496450
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitisation.
Endlicher E; Knuechel R; Hauser T; Szeimies RM; Schölmerich J; Messmann H
Gut; 2001 Mar; 48(3):314-9. PubMed ID: 11171819
[TBL] [Abstract][Full Text] [Related]
37. Role of 5-aminolevulinic acid in the diagnosis and treatment of superficial bladder cancer: improvement in diagnostic sensitivity.
De Dominicis C; Liberti M; Perugia G; De Nunzio C; Sciobica F; Zuccalà A; Sarkozy A; Iori F
Urology; 2001 Jun; 57(6):1059-62. PubMed ID: 11377304
[TBL] [Abstract][Full Text] [Related]
38. Clinical assessment of fluorescence cytoscopy during transurethral bladder resection in superficial bladder cancer.
Jichlinski P; Wagnières G; Forrer M; Mizeret J; Guillou L; Oswald M; Schmidlin F; Graber P; Van den Bergh H; Leisinger HJ
Urol Res; 1997; 25 Suppl 1():S3-6. PubMed ID: 9079749
[TBL] [Abstract][Full Text] [Related]
39. [Initial experience in the diagnosis and treatment of superficial bladder tumors with Hexvix].
Abascal Junquera JM; Hevia Suárez M; Abascal García JM; Estébanez C; Astudillo A; Abascal R
Arch Esp Urol; 2008 May; 61(4):475-82; discussion 482-3. PubMed ID: 18592765
[TBL] [Abstract][Full Text] [Related]
40. [Superficial bladder tumors. Pathological and clinical review and presentation of a new diagnostic method: fluorescence photodetection of transitional epithelial carcinomas based on protoporphyrin IX induction with delta-aminolevulinic acid (5-ALA)].
Jichlinski P; Mizeret J; Forrer M; Wagnière G; Van den Bergh H; Schmidlin F; Graber P; Leisinger HJ
Rev Med Suisse Romande; 1995 Mar; 115(3):233-7. PubMed ID: 7777763
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]